Precision Vaccines: Lessons Learned From the Coronavirus Pandemic
Clin Infect Dis
.
2022 Aug 15;75(Suppl 1):S1.
doi: 10.1093/cid/ciac300.
Authors
Asimenia Angelidou
1
2
3
,
Jay Evans
4
,
Olubukola Idoko
1
5
,
Ofer Levy
1
3
6
,
Nicole Pignatiello Lewis
1
,
Etsuro Nanishi
1
3
,
Oludare A Odumade
1
3
7
,
Al Ozonoff
1
3
6
,
Stanley Plotkin
8
,
Amy C Sherman
1
9
10
,
Simon D van Haren
1
3
,
Elissa R Weitzman
3
11
12
Affiliations
1
Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
2
Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
3
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
4
Center for Translational Medicine, University of Montana, Missoula, MT, USA.
5
The Vaccine Centre, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
6
Broad Institute of MIT & Harvard, Cambridge, MA, USA.
7
Division of Medical Critical Care, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
8
Emeritus Professor of Pediatrics, University of Pennsylvania, Doylestown, PA, USA.
9
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
10
Department of Medicine, Harvard Medical School, Boston, MA, USA.
11
Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
12
Computational Health Informatics Program, Boston Children's Hospital, Boston, MA 02115, USA.
PMID:
35439282
PMCID:
PMC9376275
DOI:
10.1093/cid/ciac300
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
COVID-19* / prevention & control
Humans
Pandemics / prevention & control
SARS-CoV-2
Vaccines*
Substances
Vaccines
Grants and funding
75N93020C00038/AI/NIAID NIH HHS/United States
HHSN272201800047C/AI/NIAID NIH HHS/United States
HHSN272201800047C/GF/NIH HHS/United States